Actively Recruiting

Phase Not Applicable
Age: 18Years +
FEMALE
ID06944392

Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function in Women with Overactive Bladder

Led by Northwestern University · Updated on 2026-04-23

40

Participants Needed

1

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating how taking pumpkin seed oil extract affects bladder function in women with overactive bladder (OAB) in the United States. The study aims to measure changes in bladder symptoms using validated surveys, focusing on patient-reported outcomes such as urinary frequency, urgency, and pelvic floor control. This pilot study seeks to better understand the impact of this dietary supplement on bladder health in a diverse U.S. population. Participants will receive a bottle of pumpkin seed oil extract (1000mg per pill) to take one pill daily for 12 weeks. They will start the supplement on the day they receive it and continue for the full study period. Patients are advised not to start new medications or supplements and not to share the pumpkin seed oil during the study. Follow-up questionnaires will be completed at 4 and 12 weeks to assess changes in bladder function, pelvic floor control, and supplement adherence. During the study, participants will complete several surveys including the Lower Urinary Tract Dysfunction Network Symptom Index-10 (LURN-SI), Pelvic Pain and Urgency/Frequency (PUF) questionnaire, and Medication Adherence Questionnaire (MAQ). Researchers will monitor patient responses to assess bladder symptoms and willingness to continue the supplement. Data will be securely stored and analyzed after the 12-week period. Participants are also advised to follow up with their urogynecologist if no improvement occurs after 3 months.

CONDITIONS

Brief Title

Evaluating Pumpkin Seed Oil Extract Supplementation on Bladder Function

Who Can Participate

Age: 18Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients evaluated at Northwestern's IPHP reporting overactive bladder symptoms (urinary urgency, frequency over 8 times daily or nocturia, with or without urgency urinary incontinence)
  • Willingness to use a dietary supplement
  • Agree not to start new behavioral, medication, or procedural treatments for 12 weeks following pumpkin seed oil extract initiation
Not Eligible

You will not qualify if you...

  • Use of other supplements containing pumpkin seed oil
  • Stage 3 or greater pelvic organ prolapse
  • Urinary post-void residual volume of 150cc or more
  • Culture-proven urinary tract infection at study enrollment
  • Recurrent urinary tract infection
  • Neurogenic bladder
  • Abdominal or pelvic malignancy
  • Initiation of new overactive bladder medications or supplements during the study period or in the 3 months before enrollment
  • History of pelvic surgery in the past 12 months for prolapse or urinary/fecal incontinence
  • Primary language not English

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) to assess symptoms and eligibility

Enrollment and Supplement Initiation

Duration - 1 day

Participants complete initial questionnaires and receive the pumpkin seed oil extract supplement to start daily use.

1 baseline visit (in-person)

Supplement Use and Monitoring

Duration - 12 weeks

Participants take one pill of pumpkin seed oil extract daily for 12 weeks while completing follow-up questionnaires to assess bladder function and supplement adherence.

Questionnaires completed at 4 weeks and 12 weeks (remote via electronic device)

Trial Site Locations

Total: 1 location

1

Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

J

Julia Geynisman-Tan, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

1

Similar Trials

The APPROVE Trial: Evaluating a Prescription Digital Therape...

Overactive Bladder (OAB)

Actively Recruiting

10 locations

Prospective, Multicenter, Single Arm Feasibility and Safety ...

Urinary Urge Incontinence (UUI)

Actively Recruiting

1 location

Characterizing the Postmenopausal Genitourinary Microbiome i...

Overactive Bladder (OAB)

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here